L-arabinose - effect on glucose metabolism
Dietary SupplementL-arabinose is mixed into the dough of the buns and cup cakes
NCT Number: NCT01801540
The purpose of this study is to investigate the effect of a meal containing different doses of L-arabinose, on the intestinal sucrase activity after intake We measure this by measuring the glucose, insulin and c-peptide after meals. Other measurements are made (glucagon and GLP-1) to explain the correlations.
Looking for future studies?
Notify Me18 year–30 year
Male
Interventional
Not applicable
Healthy volunteers accepted: Yes
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
L-arabinose is mixed into the dough of the buns and cup cakes
Time frame: -15, 0, 15, 30, 45, 60, 90, 120, 180 min
Level of glucose over time, The AUC, the peak value and time to peak
Time frame: -15, 0, 15, 30, 45, 60, 90, 120, 180 min
Level of insulin over time, the AUC, the peak value and time to peak
Time frame: -15, 0, 15, 30, 45, 60, 90, 120, 180 min
Level of c-peptide over time, The AUC, the peak value and time to peak
Time frame: -15, 0, 15, 30, 45, 60, 90, 120, 180 min
Level of glucagon over time, The AUC, the peak value and time to peak
Time frame: -15, 0, 15, 30, 45, 60, 90, 120, 180 min
Level of GLP-1 over time, The AUC, the peak value and time to peak
University of Copenhagen
Other
The Effects of L-arabinose in a Meal on Glucose Metabolism in Healthy Men
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT06685146
Glucose Metabolism, Insulin Secretion
Copenhagen, Denmark
View Trial DetailsNCT04971408
Central Nervous System Diseases, Chronic Inflammation
San Antonio, Texas, United States
View Trial DetailsNCT07330388
Antioxidant Effect, Diabetes Mellitus
Izmir, Turkey (Türkiye)
View Trial DetailsNCT06921824
Glucagon, Glucose Metabolism
Copenhagen, Denmark
View Trial Details